FindTrial
Sign In

Management of Essential Hypertension by Triphala Choorna and Medhya Rasayana

A Critical Study on Uccharaktachapa w.s.r to Essential Hypertension and its Management with Triphala Choorna and Medhya Rasayana

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056873
Enrollment
30
Registered
2023-08-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Sponsors

Dr Neha Agrawal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Stage of Grade 1 hypertension (systolic BP 140-159mmhg, Diastolic BP 90-99mmhg) Patients between 30-60years age of either sex Patients not taking antihypertensive drugs

Exclusion criteria

Exclusion criteria: Ischaemic heart disease(IHD),Coronary heart disease(CHD),Coronary artery disease(CAD) and coarctation of aorta Renal failure Endocrine diseases Hypertension with cerebral complications e.g. hypertensive encephalopathy,cerebral hemorrhage,convulsive seizure malignant hypertension pregnant and lactating mother Patients age less than 30 and greater than 60

Design outcomes

Primary

MeasureTime frame
The blood pressure of the patient will be assesed after the trialTimepoint: in 30 days—

Secondary

MeasureTime frame
The efficacy of Triphala Choorna & Medhya Rsayan Swarasa in Essential Hypertension will be assessedTimepoint: 30 Days—

Countries

India

Contacts

Public ContactProf Dr Sarita Mohanta

Government Ayurvedic College & Hospital Balangir

sagar.siba2010@gmail.com8144848636

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026